A detailed history of Lmr Partners LLP transactions in Glaukos Corp stock. As of the latest transaction made, Lmr Partners LLP holds 36,986 shares of GKOS stock, worth $5.33 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
36,986
Previous 32,927 12.33%
Holding current value
$5.33 Million
Previous $3.9 Million 23.67%
% of portfolio
0.04%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$113.62 - $135.39 $461,183 - $549,548
4,059 Added 12.33%
36,986 $4.82 Million
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $2.95 Million - $3.9 Million
32,927 New
32,927 $3.9 Million
Q3 2023

Nov 14, 2023

BUY
$69.23 - $79.09 $2.17 Million - $2.48 Million
31,350 New
31,350 $2.36 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.86B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.